RICHMOND, Va.--(BUSINESS WIRE)--May 8, 2006--Insmed Incorporated (NASDAQ:INSM - News), a biopharmaceutical company focused on the development and commercialization of drugs for the treatment of metabolic and endocrine diseases with unmet medical needs, today announced results for the three month period ended March 31, 2006.
